Evaluating allogeneic transplant for TP53 mutated acute myeloid leukemia

A new editorial was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.”

Metabolomics study finds biomarkers predicting autism in newborns

A study in Communications Biology utilized metabolomics in newborns to identify markers that might predict autism spectrum disorder (ASD), finding distinct metabolic profiles in children

May 15, 2024

DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base – Biotech Investments

DocMorris AG / Key word(s): Development of Sales DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing

January 17, 2024

Virginia governor vetoes plans to create a prescription drug affordability board

Virginia Gov. Glenn Youngkin vetoed a bill that would have created a new entity for capping the cost of prescription drugs, an increasingly popular tactic

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.